Abstract
A woman with Crohn's disease developed acute neuropathy and concomitant encephalopathy while being treated with infliximab. The etiological investigations were negative. Infliximab was stopped and she was given four series of polyvalent immunoglobulin injections. Eighteen months later, the encephalitic symptoms had disappeared and the neuropathic symptoms were less severe. TNF-alpha antagonists have been previously blamed for triggering neurological disorders, but no cases of acute neuropathy concomitant with encephalopathy have been reported so far.
Copyright 2010 Elsevier B.V. All rights reserved.
MeSH terms
-
Acute Disease
-
Anti-Inflammatory Agents / adverse effects*
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Brain / pathology
-
Brain Diseases / chemically induced*
-
Brain Diseases / pathology
-
Crohn Disease / drug therapy
-
Female
-
Humans
-
Infliximab
-
Magnetic Resonance Imaging
-
Middle Aged
-
Motor Neuron Disease / chemically induced*
-
Motor Neuron Disease / pathology
-
Neural Conduction
-
Peripheral Nervous System Diseases / chemically induced*
-
Peripheral Nervous System Diseases / pathology
-
Sensory Receptor Cells / drug effects
-
Sensory Receptor Cells / pathology
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Tumor Necrosis Factor-alpha
-
Infliximab